IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Swiss biotech developing engineered protein therapies for COVID-19 and cancers.
Industry: Health Care
Latest Trade: $3.80 0.00 (0.0%)
First Day Return: -7.5%
Return from IPO: -82.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/22/2021 |
Offer Price | $21.25 |
Price Range $21.25 - $21.25 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $64 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/15/2021 |
Offer Price | $21.25 |
Price Range $21.25 - $21.25 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $64 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | Zurich, Switzerland |
Founded | 2004 |
Employees | 152 |
Website www.molecularpartners.com |